- Report
- October 2023
Czech Republic
From €2230EUR$2,450USD£1,912GBP
- Report
- May 2021
- 225 Pages
Jordan
From €2230EUR$2,450USD£1,912GBP
- Report
- October 2022
- 274 Pages
Global
From €3249EUR$3,570USD£2,785GBP
- Report
- November 2023
- 272 Pages
Global
From €3249EUR$3,570USD£2,785GBP
- Book
- April 2018
- 312 Pages
- Book
- April 2024
- 448 Pages
- Book
- December 2023
- 864 Pages
- Book
- April 2023
- 176 Pages
- Book
- May 2021
- 512 Pages
- Book
- October 2020
- 288 Pages
- Book
- October 2020
- 600 Pages
- Book
- November 2019
- 432 Pages
- Book
- October 2019
- 632 Pages
- Book
- January 2019
- 600 Pages
- Book
- April 2018
- 776 Pages
United States
- Book
- August 2015
- 288 Pages
- Book
- April 2013
- 294 Pages
- Book
- April 2012
- 776 Pages
- Book
- November 2011
- 432 Pages

Leukemia is a type of cancer that affects the blood and bone marrow. It is a form of hematological malignancy, which is a cancer of the blood-forming cells. Leukemia is characterized by an abnormal increase in the number of white blood cells in the body, which can interfere with the normal functioning of the blood and bone marrow. Symptoms of leukemia can include fatigue, fever, anemia, and an enlarged spleen. Treatment for leukemia typically involves chemotherapy, radiation therapy, and/or stem cell transplantation.
There are several companies that are involved in the Leukemia market. These include pharmaceutical companies such as Novartis, Celgene, and Bristol-Myers Squibb, as well as biotechnology companies such as Gilead Sciences and Amgen. Additionally, there are a number of research organizations and academic institutions that are actively researching new treatments for leukemia. Show Less Read more